Skip to search formSkip to main contentSkip to account menu

FG 020326

Known as: FG-020326, FG020326 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
FG020326 Sensitized Multidrug Resistant Cancer Cells to Docetaxel-Mediated Apoptosis via Enhancement of Caspases Activation
Apoptotic resistance is the main obstacle for treating cancer patients with chemotherapeutic drugs. Multidrug resistance (MDR) is… 
2007
2007
A method for determining the concentration of FG020326 in mice plasma by RP-HPLC
Aim To establish a method to determine the concentration of FG020326 in the plasma of KM mice by reverse phase high-performance… 
2007
2007
FG020326, a novel third generation P-glycoprotein inhibitor
AACR Annual Meeting-- Apr 14-18, 2007; Los Angeles, CA 2281 Purpose: Successful chemotherapy is limited by multidrug… 
2006
2006
Reversal of multidrug resistance by a novel third generation modulator, FG020326.
5415 Purpose: Effectiveness of chemotherapeutic treatment is limited by multidrug resistance (MDR) phenomenon mediated by the… 
2004
2004
[Enhancement of FG020326 on sensitivity of MCF-7/ADR cells to taxotere via enhancing activation of caspase-8 and caspase-3].
BACKGROUND & OBJECTIVE Multidrug resistance (MDR) is often characterized by over-expression of P-glycoprotein (P-gp) as drug… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)